Scienture shareholders reject 20x authorized share increase; approve reverse split and equity plan

Scienture Holdings, Inc.

Proposal to boost authorized common shares from 100M to 2B and preferred from 10M to 200M was rejected (5.3M for, 5.5M against).
Approved amendment to 2019 Plan increasing pool from 5M to 25M shares (5.6M for, 5.2M against).
Approved potential future offering >20% of outstanding at below minimum price under Nasdaq Rule 5635(d) (5.6M for, 5.2M against).
Board granted discretion to effect reverse stock split between 1:2 and 1:50 (6.3M for, 4.7M against).
All five director nominees elected with >9.4M votes each; no broker non-votes for Proposal 5.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.